Showing results (1711-1720 of 2,025) with videos related to

Sort By:
Pageof 203
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|June 8, 2026
Bronchodilator response is linked with uncontrolled moderate-to-severe childhood asthma and elevated IL-4 and IL-13Nariman K A Metwally, Simone Hashimoto, Susanne J H Vijverberg, et al.
Cancer Medicine|May 19, 2025
FUT8 Is a Critical Driver of Prostate Tumour Growth and Can Be Targeted Using Fucosylation InhibitorsKayla Bastian, Margarita Orozco-Moreno, Huw Thomas, et al.
Molecular Cancer|September 21, 2022
The architecture of clonal expansions in morphologically normal tissue from cancerous and non-cancerous prostatesClaudia Buhigas, Anne Y Warren, Wing-Kit Leung, et al.
The Journal of Clinical Investigation|August 10, 2023
Specific quinone reductase 2 inhibitors reduce metabolic burden and reverse Alzheimer's disease phenotype in miceNathaniel L Gould, Gila R Scherer, Silvia Carvalho, et al.
ERJ Open Research|January 10, 2024
A BEAT-PCD consensus statement: a core outcome set for pulmonary disease interventions in primary ciliary dyskinesiaRenate Kos, Myrofora Goutaki, Helene E Kobbernagel, et al.
The Pharmacogenomics Journal|February 22, 2020
Genome-wide association study of angioedema induced by angiotensin-converting enzyme inhibitor and angiotensin receptor blocker treatmentEva Rye Rasmussen, Pär Hallberg, Ekaterina V Baranova, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 9, 2023
Real-World Effectiveness of IL-5/5Ra Targeted Biologics in Severe Eosinophilic Asthma With Comorbid BronchiectasisSarah A Bendien, Johannes A Kroes, Lotte H G van Hal, et al.
Clinical and Experimental Rheumatology|December 3, 2016
Utility of B-type natriuretic peptides in the assessment of patients with systemic sclerosis-associated pulmonary hypertension in the PHAROS registryLorinda Chung, Robert M Fairchild, Daniel E Furst, et al.
Clinical Pharmacology and Therapeutics|October 2, 2013
Cholesteryl ester transfer protein polymorphisms, statin use, and their impact on cholesterol levels and cardiovascular eventsM Leusink, N C Onland-Moret, F W Asselbergs, et al.
Pageof 203